Fig. 4From: HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort studya Treatment prevalence by age group among participants with and without substance use disorder in the TOHVHP HCV cohort – Treated with IFN (n = 178) b Treatment prevalence by age group among participants with and without substance use disorder in the TOHVHP HCV cohort – Treated with DAA (n = 563)Back to article page